Conducts and supports research on the prevention and early detection of head and neck and lung cancers. Clinical trials and the evaluation of new agents, surrogate biomarkers, and new technologies to identify premalignant lesions are developed and supported.
This is a listing of Requests for Applications specific to the group’s key programs.
Research focuses on Phase II lung cancer and head and neck cancer prevention trials.
Mission, staff list, and contact information are in this section.
Back to top
